Ventus Therapeutics
ID: 7648533Small Molecules targeting proteins in the inflammasome and nucleic acid sensing signaling pathways
3
Funding Rounds
$300.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Ventus Therapeutics has raised a total of $300m in funding over 3 rounds.
Key Insights:
- Ventus Therapeutics Series C round, February 2022: $140m
- Ventus Therapeutics Series B round, April 2021: $100m
- Ventus Therapeutics Series A round, May 2020: $60m
Industries
Ventus Therapeutics is active in the following industries: